Wednesday, January 24, 2018
News
NEWS HOME
»
PRESS RELEASES

Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine
  SocialTwist Tell-a-Friend  
   


Date: 12-01-2018 12:50PM
Source: Ferring Pharmaceuticals
Category: General, Science & Research, Banking & Financial Services, Education & Training, Healthcare & Biotechnology, Pharmaceutical, Business Services, Technology
Location: Saint-Prex, Switzerland

Business Wire India

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180110006148/en/

As part of the agreement, a new jointly funded laboratory will be created within the CAS research facility in Beijing, China. Known as the ‘Ferring Institute of Reproductive Medicine’, the facility will bring together researchers from both Ferring and CAS to find solutions to address global challenges in fertility and high rates of obstetric complications.

“Across the world, too many couples still face considerable challenges when trying to become families,” said Per Falk, Executive Vice President and Chief Scientific Officer, Ferring Pharmaceuticals. “This collaboration forms the next phase in our ongoing efforts to advance knowledge and care in reproductive medicine and women’s health. Working together we hope to gain a deeper understanding of fertility and implantation and discover new solutions that could transform the way in which reproductive medicine is managed in the future.”

“Our collaboration with Ferring will expand our research base into the translational space and together we will rapidly expand our tool set to look at truly transformational ideas in reproductive medicine,” said Prof Hongmei Wang, Director of the State Key Laboratory of Stem Cell and Reproductive Biology at the Institute of Stem Cell and Regeneration, Chinese Academy of Sciences.

For CAS, the collaboration will provide additional expertise and funding to support their world-class stem cell research and regenerative medicine programme, a core element of their Innovation 2030: Building Tomorrow initiative. For Ferring, the collaboration will help to identify new therapeutic concepts and targets that will enable the discovery of novel drug candidates that may be further developed to address unmet needs in reproductive medicine and women’s health.

“CAS is already recognised as a leading life science institute for our early basic research in reproductive biology, which covers most aspects of female and male infertility and obstetric complications,” said Prof Qi Zhou, Director of the Institute of Stem Cell and Regeneration and the Institute of Zoology, Chinese Academy of Sciences. “We welcome this collaboration which will help us to reach our Innovation 2030 goal and improve reproductive health both in China and worldwide.”

- Ends -

About Ferring Pharmaceuticals:

Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. A leader in reproductive medicine and women’s health, Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative treatments to help mothers and babies, from conception to birth. The company also identifies, develops and markets innovative products in the areas of urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com.

Ferring is on Twitter. Follow us @FerringNews at http://twitter.com/FerringNews

About the Chinese Academy of Sciences (CAS):

The Chinese Academy of Sciences (CAS) is the largest national research organisation in China focused on exploring and harnessing technology and the natural sciences for the benefit of China and the world. CAS comprises 104 research institutes, containing in excess of 300 national and CAS key labs and engineering centres, 12 branch academies, three universities and 11 supporting organisations in 23 provincial-level areas across the country. With over 68,000 researchers, CAS brings together scientists and engineers from China and around the world to conduct research in most areas of breakthrough science and technology.


MULTIMEDIA AVAILABLE :
http://www.businesswire.com/news/home/20180110006148/en/


CONTACTS :

Ferring Corporate Communications Team:
Lindsey Rodger
Senior Manager, Corporate Communications
+41 58 451 4023 (direct)
+41 79 191 0486 (mobile)
lindsey.rodger@ferring.com
or
Bhavin Vaid
Head of Corporate Communications
+41 58 301 0952 (direct)
+41 79 191 0632 (mobile)
bhavin.vaid@ferring.com
or
Chinese Academy of Sciences:
Wei Li
Vice Director, Corporate Communications
+86-10-64807297 (direct)
+86-15210478009 (mobile)
liwei@ioz.ac.cn

More Press Releases

BMW India Announces an Exclusive Partnership with Bengaluru International Airport

Häfele Unites Design Possibilities with Form and Functionality at its New State-of-the-art Showroom in Bangladesh

IC3 Announces the Third Edition of the 2018 Annual IC3 Conference to Provide an Impetus to Career Counseling in High Schools

Large Deals across Multiple Verticals Drive a 26 percent YoY USD Revenue Growth for L&T Technology Services

Commvault Powers New HPE GreenLake Backup Solution to Bring Enterprise-class Data Protection and Reliability to Customers

European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy– Providing an Innovative Treatment Option to Patients

Hilton Led Hospitality Industry in Customer Innovations and Recorded Best Ever Growth in 2017

HackerEarth Recruit Continues Exceptional Customer Momentum; Used by More than 4000 Enterprises

MAIT Strongly Advocates "Make in India for the World" through its Electronics Manufacturing Summit

Calvin Klein, Inc. Announces the Spring/Summer 2018 Calvin Klein Underwear and Calvin Klein Jeans Global Advertising Campaign

Ferring enters into worldwide OmniAb® platform license agreement with Ligand

Hybrid and Electric Vehicle Growth in India Driven by Government Incentives and Changing Customer Attitudes

Panasonic LUMIX GH5 Supports Yasunaga Ogita, a Polar Explorer, in Japan's First Solo South Pole Expedition Without Resupplies

Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India

New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients

Octapharma:Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Treamis World School Marks its Decennial Celebrations in Style!

Green Initiatives in India to be Recognized at the One Globe Awards

Dailyhunt Launches Newzly, a News-in-Brief App, in Nine Languages

Jaipuria Group Plans to Invest 500 crores for Expansion across 5 States

 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
Shoe hurled at Owaisi...
3 districts to implement Rashtriya Vayos...
Militants nabbed, arms, ammunitions sei...
Congress candidate list for Meghalaya po...
ACC F2R Super Fast launched in Odisha...
TMC leader Partha Chatterjee visits BJP ...
More...    
 
 Top Stories
Twitter COO Anthony Noto quits, joi... 
Google brings audiobooks on Play St... 
Chill grips J&K as gap between maxi... 
Facebook acquires biometric ID veri... 
Markets open on a negative note on ... 
New population of 'walking fish' fo... 
Over 10,000 killed in last 40 month... 
Vyapam Scam: Member of People's Col...